hepatitis C

Merck lowers prices of some drugs after Trump calls out industry
Yahoo/Reuters
Fri, 07/20/18 - 09:38 am
Merck
drug pricing
Donald Trump
hepatitis C
Private Insurers Deny Over Half of All Claims for Hepatitis C Drugs
Xtalks
Fri, 06/8/18 - 11:05 am
hepatitis C
insurers
Balm for Gilead: Unclean Hands Render Patents Unenforceable
JD Supra
Thu, 06/7/18 - 10:54 pm
Merck
Gilead Sciences
patents
hepatitis C
The hepatitis C duopoly
Axios
Fri, 04/27/18 - 10:26 pm
AbbVie
hepatitis C
Gilead Sciences
U.S. court upholds dismissal of $200 million Merck verdict against Gilead
Reuters
Thu, 04/26/18 - 07:31 pm
Merck
Gilead Sciences
patents
hepatitis C
This Small Biotech Is Building on a Surprising Success
Motley Fool
Wed, 04/25/18 - 09:32 am
AbbVie
Mavyret
Enanta Pharmaceuticals
glecaprevir
hepatitis C
Conatus Pharma’s Liver Disease Drug Flunks First Phase 2 Test
Xconomy
Thu, 04/5/18 - 11:57 pm
Conatus Pharmaceuticals
clinical trials
Novartis
emricasan
liver disease
hepatitis C
5 Must-See Quotes From AbbVie's Management
Yahoo/Motley Fool
Fri, 03/16/18 - 09:27 am
AbbVie
Humira
hepatitis C
Mavyret
Viekira
M&A
Is Gilead Sciences Trying to Put Itself Out of Business?
Motley Fool
Wed, 03/14/18 - 09:31 pm
Gilead Sciences
hepatitis C
HIV
GS-9620
PGT121
[video]How Pricing Can Be Vital to a Drugmaker's Profitability
Motley Fool
Mon, 03/12/18 - 09:39 am
drug pricing
Gilead Sciences
AbbVie
hepatitis C
Gilead Sciences' History Points to Future Success
Motley Fool
Thu, 03/1/18 - 11:49 pm
Gilead Sciences
hepatitis C
NASH
What's beyond hepatitis C in the drug launch hit parade? Ibrance and Tecfidera, for two
Fierce Pharma
Mon, 02/26/18 - 11:30 am
drug launches
hepatitis C
Ibrance
Tecfidera
Biogen
Pfizer
Gilead Sciences
Gilead wins reprieve in Merck's $2.5B patent lawsuit
Biopharma Dive
Thu, 02/22/18 - 09:52 am
Gilead Sciences
Merck
patents
Sovaldi
Harvoni
hepatitis C
Idenix
Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict
Reuters
Sun, 02/18/18 - 10:10 am
Gilead Sciences
hepatitis C
patents
Merck
Sovaldi
Harvoni
Dogged by AbbVie's new share-stealing Mavyret, Gilead's hep C forecast comes in far short
Fierce Pharma
Thu, 02/8/18 - 09:14 am
AbbVie
Mavyret
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
NICE nods for AbbVie in hep C and Novartis in lung cancer
Pharma Times
Sun, 12/10/17 - 09:53 am
NICE
AbbVie
hepatitis C
Maviret
Novartis
Zykadia
ALK-positive non-small cell lung cancer
Gilead prices hepatitis C giant Sovaldi in China at one-fifth the U.S. price: report
Fierce Pharma
Tue, 11/28/17 - 11:07 am
Gilead Sciences
hepatitis C
Sovaldi
China
drug pricing
The 1 Thing Missing From Gilead Sciences' 2018 Priority List
Motley Fool
Tue, 11/21/17 - 10:37 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Epclusa
What's Behind Gilead Sciences Inc.'s $7.8 Billion Slide in October?
Motley Fool
Thu, 11/2/17 - 10:06 pm
Gilead Sciences
hepatitis C
Gilead warns hep C sales could fall further
BioPharma Dive
Fri, 10/27/17 - 11:01 am
Gilead Sciences
earnings
hepatitis C

Pages